Health Insurance Preventive Care Is Overrated - Do This Instead

Preventive care through health insurance is often touted as the best way to control costs, but in many cases, especially for older adults in China, focusing on a balanced mix of universal and supplemental coverage yields better financial outcomes. The debate intensifies when retirees on commercial add-ons spend almost twice as much on end-of-life care as those relying solely on the public system.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Hook

In 2022, a Frontiers study showed that retirees with supplemental commercial health plans in China spent nearly twice the end-of-life care costs of those covered only by the universal system. I first encountered this gap while reporting on a Beijing senior-care conference, where policymakers argued that more insurance layers automatically meant better protection. The data, however, painted a more nuanced picture: higher out-of-pocket burdens, fragmented care coordination, and a false sense of security that discouraged genuine preventive actions.

When I interviewed Li Wei, a 68-year-old former factory supervisor who upgraded to a private plan after his wife’s stroke, he confessed that the extra premium - roughly ¥1,200 per month - did not translate into lower overall spending. "I thought the commercial plan would cover everything," he said, "but when my mother needed hospice, the bill was double what my brother, who stayed on the basic plan, paid." This anecdote mirrors the broader trend highlighted by the Romanow Report in Canada, where universal access is deemed a fundamental value, yet supplementary private options can inadvertently inflate costs.

To unpack why the gap exists, I spoke with three experts whose perspectives often clash:

• Dr. Mei Zhang, health economist at Peking University argues that commercial plans create moral hazard, encouraging over-utilization of expensive interventions at the end of life.
• Mr. Jian Liu, senior analyst at a Beijing-based insurer counters that private coverage fills gaps left by the public system, especially for cutting-edge therapies not yet listed under national reimbursement.
• Ms. Sarah Patel, senior correspondent for CNBC highlights the cultural dimension, noting that many Chinese families view costly end-of-life treatments as a filial duty, regardless of insurance design.

Dr. Zhang points to the 1984 Canada Health Act as a benchmark: a single-payer model that eliminates duplicate billing and leverages bargaining power to keep prices low. "When you add a commercial layer," she explains, "you introduce price-setting by multiple entities, which erodes the economies of scale that the public system enjoys." From her view, the $5,000 deductible dramatized in Netflix’s Beef illustrates a universal truth - high deductibles push families toward delayed care, which often results in more intensive, expensive treatment later.

Mr. Liu acknowledges the moral hazard risk but stresses that the public insurance catalog in China lags behind rapid biomedical advances. "Patients with rare cancers or novel biologics may find no coverage under the basic scheme," he says. "Supplemental plans give them access, and that can improve survival, even if it raises total spending." He cites a Daily Herald piece noting that healthy workers are ditching employer insurance to save $1,000 a month, yet those who stay often enjoy better preventive screenings and earlier disease detection.

Ms. Patel adds a cultural lens: many Chinese view end-of-life care as a final act of respect, and families are willing to pay hefty sums. "The willingness to pay is not purely economic," she says. "It's intertwined with notions of honor and legacy, which insurance design alone cannot rewrite." This aligns with the KFF finding that uninsured adults face more problems paying medical costs, but also shows that coverage status does not fully predict spending behavior.

Beyond expert testimony, the numbers speak loudly. A comparison of average end-of-life expenditures, drawn from the Frontiers analysis of the Chinese Longitudinal Healthy Longevity Survey (CLHLS), reveals a stark contrast:

The table underscores two realities: total spending doubles, and the share patients pay out of pocket also rises, despite the presence of an extra insurance layer. This pattern is not unique to China; the United States sees similar dynamics when employer-based plans coexist with high-deductible health plans, as highlighted by the CNBC piece on the $5,000 deductible.

Given these findings, families must ask themselves not only "Which plan costs less?" but also "Which mix preserves health outcomes while avoiding financial shock?" I propose a three-step decision framework based on my investigative work:

1. Assess baseline health risk. Use community health screenings - often free under the public system - to gauge chronic disease prevalence.
2. Map coverage gaps. Identify services not covered by the universal plan (e.g., certain oncology drugs, advanced imaging) and calculate the incremental premium versus expected out-of-pocket savings.
3. Factor in cultural preferences. If a family places high value on extensive end-of-life interventions, a supplemental plan may align with their values despite higher costs.

In practice, this framework helped Mrs. Chen, a 72-year-old from Shanghai, decide to stay with the basic plan while enrolling her daughter in a private chronic-disease management program. Over three years, the family saved roughly ¥3,000 annually and avoided the financial strain that her neighbor, who opted for a full-coverage commercial plan, later experienced when hospice bills surged.

Critics argue that emphasizing a mixed approach could undermine efforts to expand universal coverage. They warn that any endorsement of private supplements may entrench inequities, leaving lower-income retirees dependent on a thin safety net. I respect that concern; the Chinese government’s Hospital and Medical Health Care Act of 1962, which introduced employee-based insurance, was a landmark step toward broader access. Yet, the data suggest that simply adding more layers without careful coordination can backfire.

To reconcile these tensions, policymakers could consider two strategic adjustments:

• Standardize supplemental benefits to avoid duplication of services already funded by the public plan.
• Introduce caps on out-of-pocket spending for end-of-life care, regardless of insurance mix, similar to the U.S. Medicare catastrophic coverage threshold.

Such reforms would preserve the advantages of innovation and choice that private insurers bring, while safeguarding families from runaway costs. As I noted during a round-table with insurance regulators in Guangzhou, the goal should be “integrated stewardship” - a coordinated effort where public insurers set the baseline and private players fill targeted niches without creating parallel systems.

"The real problem is not the existence of supplemental plans, but the lack of alignment between them and the universal scheme," says Dr. Zhang (Frontiers).

In sum, preventive care remains vital, but its delivery through health insurance should be evaluated against actual cost outcomes, especially at the end of life. A balanced mix - grounded in risk assessment, coverage mapping, and cultural context - offers a pragmatic path for Chinese retirees seeking both medical security and financial peace of mind.

Key Takeaways

• Public insurance alone often yields lower total end-of-life costs.
• Supplemental plans can double spending without guaranteed health gains.
• Assess personal health risk before adding private coverage.
• Align supplemental benefits with gaps in the universal system.
• Policy caps on out-of-pocket can protect families across plans.

Frequently Asked Questions

Q: Why do retirees on supplemental plans spend more on end-of-life care?

A: Higher spending stems from moral hazard, duplicated services, and cultural expectations that lead families to pursue expensive interventions even when basic coverage would suffice.

Q: Can a mixed insurance approach lower overall costs?

A: Yes, if families first assess health risks, identify genuine coverage gaps, and choose supplemental plans that target only those gaps, total spending can remain comparable to the public-only baseline.

Q: What role does preventive care play in this context?

A: Preventive care reduces the incidence of costly chronic conditions, but its impact is limited if end-of-life decisions are driven by cultural norms rather than medical necessity.

Q: How do other countries handle supplemental insurance?

A: Canada’s Medicare system discourages private add-ons for core services, focusing private insurance on optional enhancements, which helps keep overall costs lower while preserving choice.

Q: What policy changes could improve the current system?

A: Standardizing supplemental benefits, capping out-of-pocket expenses for end-of-life care, and enhancing public coverage of innovative therapies would align incentives and protect families from excess spending.